By understanding the regulatory mechanisms behind B7-H6 expression, as well as its intrinsic and extrinsic pathways, researchers can develop therapies that not only target B7-H6 directly but also enhance the broader immune response against cancers. The gene discussed is NCR3LG1; the disease is cancer.